Authors

Ezra Cohen, MD, UCSD

Ezra Cohen, MD, University of Chicago

Ezzat Elhassadi, MD

Latest:

Dr. Elhassadi on the Subtypes of MCL

Ezzat Elhassadi, MD, consultant hematologist, Hematology Services, University Hospital Waterford, discusses the subtypes of mantle cell lymphoma (MCL).

F. Anthony Greco, MD, Sarah Cannon Cancer Center

F. Nery Flores, MD

Latest:

Focal Therapy Evolves Into More Precise Treatment in Prostate Cancer

Historically, the management of localized prostate cancer has centered on removal or ablation of the entire gland with either extirpative surgery or radiation. However, the subsequent unacceptable adverse events profile can be devastating and life altering for many patients.

F. Stephen Hodi, MD

Latest:

Dr. Hodi on Long-Term Survival Data for Nivolumab in Melanoma

F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, discusses the results of the longest follow-up survival study of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

Fabrice Andre

Latest:

Dr. Andre on the Impact of the SOLAR-1 Findings in Breast Cancer

Fabrice André, MD, PhD, professor, Department of Medical Oncology, Institut Gustave Roussy, discusses the impact of the SOLAR-1 findings in breast cancer at the 2018 ESMO Congress.

Fabrice Andre, MD, PhD

Latest:

Dr. Andre on Strategies to Improve Outcomes in Breast Cancer

Fabrice André, MD, PhD, discusses strategies to improve outcomes in patients with breast cancer.

FACP, University of Pittsburgh School of Medicine

Fadi Braiteh, MD, Comprehensive Cancer Centers of Nevada

Fadi Braiteh, MD, CPI, CCC Nevada

Fadi Braiteh, MD, University of Nevada School of Medicine

Fadi S. Braiteh, MD

Faisal Musa, MD

Latest:

Do We Still Need Physical Exams in the Era of Advanced Imaging Technologies?

Throughout fellowship, my experiences working with patients in clinic have taught me many lessons.

Faith Davies, MD, MBBCh, MRCP, FRCPath, University of Arkansas for Medical Sciences

Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center

Latest:

Dr Davies on Addressing Global Gaps in Multiple Myeloma Care

Faith E. Davies, MD, discusses strategies for rectifying global gaps and addressing unmet needs in multiple myeloma care.

Farah Succaria, MD

Latest:

Dr. Succaria on Targetable Immune Checkpoints in Head and Neck Cancer

Farah Succaria, MD, postdoctoral fellow, Johns Hopkins Medicine, discusses targetable immune checkpoints in head and neck squamous cell carcinoma.

Fard Johnmar

Latest:

Wellsphere Blogger Flap Raises Questions about Content Ownership

It started with an e-mail to thousands of health bloggers from Dr. Geoff Rutledge, Chief Medical Information Officer at the health website Wellsphere.

Farhad Kosari, PhD

Latest:

Dr. Kosari on Antitumor Immunity in Small Cell Lung Cancer

Farhad Kosari, PhD, assistant professor of Biochemistry and Molecular Biology, discusses anti-tumor immunity as a key determinant for small-cell lung cancer (SCLC) survivorship.

Farhad Ravandi-Kashani, MD

Latest:

Dr Ravandi-Kashani on the FDA Approval of Luspatercept in MDS

Farhad Ravandi-Kashani, MD, discusses the FDA approval of luspatercept in myelodysplastic syndrome.